Abigail Jacobs

2.6k total citations
41 papers, 1.6k citations indexed

About

Abigail Jacobs is a scholar working on Cancer Research, Small Animals and Molecular Biology. According to data from OpenAlex, Abigail Jacobs has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 10 papers in Small Animals and 8 papers in Molecular Biology. Recurrent topics in Abigail Jacobs's work include Carcinogens and Genotoxicity Assessment (13 papers), Animal testing and alternatives (10 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Abigail Jacobs is often cited by papers focused on Carcinogens and Genotoxicity Assessment (13 papers), Animal testing and alternatives (10 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Abigail Jacobs collaborates with scholars based in United States, Netherlands and United Kingdom. Abigail Jacobs's co-authors include Joseph F. Contrera, Joseph J. DeGeorge, David Jacobson‐Kram, Joanna Matheson, Warren Casey, Timothy W. Robison, Judy Strickland, David Allen, Nicole Kleinstreuer and Paul C. Brown and has published in prestigious journals such as Applied Physics Letters, Environmental Health Perspectives and International Journal of Molecular Sciences.

In The Last Decade

Abigail Jacobs

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abigail Jacobs United States 25 428 406 365 253 239 41 1.6k
Edward W. Carney United States 30 343 0.8× 790 1.9× 658 1.8× 206 0.8× 157 0.7× 88 2.6k
Richard N. Hill United States 19 289 0.7× 218 0.5× 359 1.0× 274 1.1× 82 0.3× 47 1.5k
Lutz Müller Germany 19 1.2k 2.9× 766 1.9× 647 1.8× 408 1.6× 312 1.3× 43 2.1k
Nicola J. Hewitt Germany 28 392 0.9× 600 1.5× 497 1.4× 511 2.0× 186 0.8× 105 3.0k
Miriam N. Jacobs United Kingdom 21 207 0.5× 392 1.0× 710 1.9× 106 0.4× 190 0.8× 55 1.7k
John E. Doe United Kingdom 19 559 1.3× 261 0.6× 727 2.0× 318 1.3× 146 0.6× 46 1.7k
Paul Brantom United Kingdom 15 311 0.7× 279 0.7× 335 0.9× 224 0.9× 75 0.3× 38 1.1k
Willi Suter Switzerland 23 553 1.3× 534 1.3× 293 0.8× 117 0.5× 74 0.3× 63 1.4k
Srilatha Sakamuru United States 28 256 0.6× 964 2.4× 474 1.3× 236 0.9× 685 2.9× 69 2.5k
Denise E. Robinson United States 19 407 1.0× 720 1.8× 446 1.2× 329 1.3× 292 1.2× 24 2.8k

Countries citing papers authored by Abigail Jacobs

Since Specialization
Citations

This map shows the geographic impact of Abigail Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abigail Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abigail Jacobs more than expected).

Fields of papers citing papers by Abigail Jacobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abigail Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abigail Jacobs. The network helps show where Abigail Jacobs may publish in the future.

Co-authorship network of co-authors of Abigail Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Abigail Jacobs. A scholar is included among the top collaborators of Abigail Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abigail Jacobs. Abigail Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emery, Rebecca L., et al.. (2024). Patient Preferences for Telemental Health Care in a Federally Qualified Health Center. Telemedicine Journal and e-Health. 31(4). 483–489.
2.
Yohannes, Daniel, Abigail Jacobs, Ming Yu, et al.. (2023). High density fabrication process for single flux quantum circuits. Applied Physics Letters. 122(21). 9 indexed citations
3.
Jacobs, Miriam N., Annamaria Colacci, Raffaella Corvi, et al.. (2020). Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens. Archives of Toxicology. 94(8). 2899–2923. 81 indexed citations
4.
Andrews, Paul A., Diann Blanset, Martin Green, et al.. (2019). Analysis of exposure margins in developmental toxicity studies for detection of human teratogens. Regulatory Toxicology and Pharmacology. 105. 62–68. 11 indexed citations
5.
Strickland, Judy, David Allen, Simona Bancos, et al.. (2018). Skin sensitization testing needs and data uses by US regulatory and research agencies. Archives of Toxicology. 93(2). 273–291. 18 indexed citations
6.
Strickland, Judy, Amy J. Clippinger, Jeffrey Brown, et al.. (2018). Status of acute systemic toxicity testing requirements and data uses by U.S. regulatory agencies. Regulatory Toxicology and Pharmacology. 94. 183–196. 66 indexed citations
7.
Felter, Susan P., Jennifer E. Foreman, Alan R. Boobis, et al.. (2017). Human relevance of rodent liver tumors: Key insights from a Toxicology Forum workshop on nongenotoxic modes of action. Regulatory Toxicology and Pharmacology. 92. 1–7. 50 indexed citations
8.
Brannen, Kimberly, et al.. (2016). Alternative Models of Developmental and Reproductive Toxicity in Pharmaceutical Risk Assessment and the 3Rs. ILAR Journal. 57(2). 144–156. 50 indexed citations
9.
Jacobs, Abigail & Paul C. Brown. (2015). Regulatory Forum Opinion Piece*. Toxicologic Pathology. 43(5). 605–610. 29 indexed citations
10.
Casey, Warren, Abigail Jacobs, Elizabeth A. Maull, et al.. (2015). A new path forward: the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and National Toxicology Program's Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM).. PubMed. 54(2). 170–3. 21 indexed citations
11.
Shen, Jie, Lei Xu, Hong Fang, et al.. (2013). EADB: An Estrogenic Activity Database for Assessing Potential Endocrine Activity. Toxicological Sciences. 135(2). 277–291. 56 indexed citations
12.
Gao, Hongying, Abigail Jacobs, Ronald E. White, Brian Booth, & R. Scott Obach. (2013). Meeting Report: Metabolites in Safety Testing (MIST) Symposium—Safety Assessment of Human Metabolites: What’s REALLY Necessary to Ascertain Exposure Coverage in Safety Tests?. The AAPS Journal. 15(4). 970–973. 24 indexed citations
13.
Laan, Jan Willem van der, et al.. (2012). Testing strategies for embryo-fetal toxicity of human pharmaceuticals. Animal models vs. in vitro approaches. Regulatory Toxicology and Pharmacology. 63(1). 115–123. 28 indexed citations
14.
Boverhof, Darrell R., M. Chamberlain, Clifford R. Elcombe, et al.. (2011). Transgenic Animal Models in Toxicology: Historical Perspectives and Future Outlook. Toxicological Sciences. 121(2). 207–233. 58 indexed citations
15.
Wang, Tao, David Jacobson‐Kram, Anne M. Pilaro, et al.. (2010). ICH Guidelines: Inception, Revision, and Implications for Drug Development. Toxicological Sciences. 118(2). 356–367. 10 indexed citations
16.
Cohen, Samuel M., Richard D. Storer, Kay A. Criswell, et al.. (2009). Hemangiosarcoma in Rodents: Mode-of-Action Evaluation and Human Relevance. Toxicological Sciences. 111(1). 4–18. 73 indexed citations
17.
Chen, Ping‐Hung, Sue Rovi, Judy C. Washington, et al.. (2007). Randomized Comparison of 3 Methods to Screen for Domestic Violence in Family Practice. The Annals of Family Medicine. 5(5). 430–435. 56 indexed citations
18.
Kauffman, John F., Benjamin J. Westenberger, J. David Robertson, et al.. (2007). Lead in pharmaceutical products and dietary supplements. Regulatory Toxicology and Pharmacology. 48(2). 128–134. 28 indexed citations
19.
Jacobs, Abigail. (2006). Use of nontraditional animals for evaluation of pharmaceutical products. Expert Opinion on Drug Metabolism & Toxicology. 2(3). 345–349. 28 indexed citations
20.
Tweats, David, David H. Blakey, Robert H. Heflich, et al.. (2006). Report of the IWGT working group on strategy/interpretation for regulatory in vivo tests. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 627(1). 92–105. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward W. Carney Breakdown of academic impact, for papers by Richard N. Hill Breakdown of academic impact, for papers by Lutz Müller Breakdown of academic impact, for papers by Nicola J. Hewitt Breakdown of academic impact, for papers by Miriam N. Jacobs Breakdown of academic impact, for papers by John E. Doe Breakdown of academic impact, for papers by Paul Brantom Breakdown of academic impact, for papers by Willi Suter Breakdown of academic impact, for papers by Srilatha Sakamuru Breakdown of academic impact, for papers by Denise E. Robinson
Rankless by CCL
2026